Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study

Jeka, S., Dokoupilová, E., Kivitz, A. et al. (9 more authors) (2024) Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study. Journal of Bone and Mineral Research, 39 (3). pp. 202-210. ISSN 0884-0431

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: bone modeling and remodeling: biochemical markers of bone turnover; clinical trials; diseases and disorders of/related to bone: osteoporosis; Female; Humans; Osteoporosis, Postmenopausal; Denosumab; Biosimilar Pharmaceuticals; Bone Density Conservation Agents; Bone Density; Osteoporosis
Dates:
  • Published: March 2024
  • Published (online): 29 January 2024
  • Accepted: 29 January 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 19 Jun 2024 15:06
Last Modified: 19 Jun 2024 15:06
Published Version: http://dx.doi.org/10.1093/jbmr/zjae016
Status: Published
Publisher: Oxford University Press (OUP)
Refereed: Yes
Identification Number: 10.1093/jbmr/zjae016
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics